<?xml version="1.0" encoding="UTF-8"?>
<ack id="bjh15459-sec-0016">
 <title>Acknowledgements</title>
 <p>The authors thank all the patients, investigators, and staff at participating centres who made this study possible; Professor David Bowen; the MRC Leukaemia Data Monitoring and Ethics Committee; the MRC Leukaemia Trial Steering Committee; the UK National Cancer Research Institute Haematological Oncology Clinical Studies Group; Myeloma UK; and the National Institute for Health Research, for support through the National Cancer Research Network. The Medical Research Council (London, UK; [G0100132]) was the primary funder of the study, with further unrestricted educational grants from Novartis, Schering Health Care, Chugai, Pharmion, Celgene Corporation, and Ortho Biotech.</p>
</ack>
